Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
doi: 10.1210/er.2012-1055 75 StanickaSVondraKPelikanovaTVlcekPHillMZamrazilV
Cant C, Auwerx J
Not EllieMD may not work for patients who want access to brand-name GLP-1s
CagriSema (cagrilintide + semaglutide) CagriSema is a fixed-dose combination of cagrilintide (a long-acting amylin analog) and semaglutide (the GLP-1 agonist behind Ozempic and Wegovy)
*This is a self-pay program, meaning no insurance is required
Many employers manage utilization by implementing: Prior authorization BMI requirements Physician documentation Lifestyle coaching Nutrition programs Step therapy Ongoing clinical reviews These guardrails help ensure medications are prescribed appropriately while helping employers better manage long-term costs
US$ 25.22
US$ 28.19
US$ 22.69
US$ 20.43
US$ 26.28
